7498 Results (Page 207 of 300)
Pharmaceuticals Markets Research Reports
Thailand Cancer Immunotherapy Market Analysis
Thailand's cancer immunotherapy market is expected to witness growth from $135 Mn in 2022 to $240 Mn in 2030 with a CAGR of 7.4% for the forecasted year 2022-30. The increasing incidence of cancer and the improvements in healthcare spending in Thailand are responsible for the growth of the market. The Thailand cancer immunotherapy market is segmented by type, application, and end user. Silom Medical, Emergpharma, and Bayer are the major players in the Thailand cancer immunotherapy market.
Thailand Antifungal Drugs Market Analysis
This report presents a strategic analysis of the Thailand Antifungal Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Thailand Antifungal Drugs Market, offering unmatched value, accuracy, and expert insights.
France Addiction Therapeutics Market Analysis
France addiction therapeutics market was valued at $278 Mn in 2022 and is estimated to reach $438 Mn in 2030, exhibiting a CAGR of 5.9% during the forecast period. The market for addiction treatments is being driven primarily by the growing recognition and understanding of substance use disorders as a serious public health issue. Major players in the market includes Indivior, Reckitt Benckiser Pharmaceuticals, Sanofi, Ethypharm, Mundipharma, Bioprojet Pharma, GlaxoSmithKline, Pfizer, Novartis and Merck KGaA
Egypt Addiction Therapeutics Market Analysis
Egypt addiction therapeutics market was valued at $28 Mn in 2022 and is estimated to reach $54 Mn in 2030, exhibiting a CAGR of 8.4% during the forecast period. The industry for addiction treatment is expanding as a result of public awareness raised by anti-drug campaigns and supportive government initiatives. Dominant key players operating in the market include Indivior, Alkermes, Reckitt Benckiser, Otsuka Pharmaceutical Co., Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical and Novartis
Canada Addiction Therapeutics Market Analysis
Canada addiction therapeutics market was valued at $808 Mn in 2022 and is estimated to reach $1378 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. One of the key elements driving development in the addiction therapeutics market is increase in drug awareness campaigns and addiction & rehab centres among the population. Leading key players functioning in the market include Alkremes, Teva Pharmaceutical Industries, Glenmark Pharmaceuticals, Titan Pharmaceuticals, Pfizer, Inc., GSK, Johnson & Johnson, Perrigo, Cipla, Hikma Pharmaceuticals, Dr. Reddy’s Laboratories Limited, Indivior, and Mylan N.V
Brazil Addiction Therapeutics Market Analysis
Brazil addiction therapeutics market was valued at $253 Mn in 2022 and is estimated to reach $464 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The industry has grown as a result of several awareness efforts and government programs designed to discourage drug addiction and support medicine. Innovations in this field are being driven by major participants in the industry, including Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Titan Pharmaceutical, Novartis, Cipla, Mylan, Glenmark, and Alkermes.
Tanzania Radiotherapy Market Analysis
The Radiotherapy Therapeutics Market in Tanzania is dominated by a few domestic players such as Ocean Road Cancer Institute, Varian Medical Systems, and Siemens. The radiotherapy market in Tanzania is segmented into different types, technology, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Tanzania Radiotherapy is increasing due to the rise in cancer cases in the country.
Tanzania Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Tanzania Oncology Therapeutics Market will reach a value of $148 Mn from $73 Mn in 2022, growing at a CAGR of 9.3% during 2022-30. The Oncology Therapeutics Market in Tanzania is dominated by a few domestic pharmaceutical companies such as MCL Pharmaceuticals, Labatec Pharma, and Pristine Pharma. The Oncology Therapeutics Market in Tanzania is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Tanzania Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Tanzania Neurology Drugs Market Analysis
This report presents a strategic analysis of the Tanzania Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Tanzania Neurology Drugs Market, offering unmatched value, accuracy, and expert insights.
Tanzania Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Tanzania Lung Cancer Therapeutics Market will reach a value of $24 Mn from $12 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The Lung Cancer Therapeutics Market in Tanzania is dominated by a few domestic pharmaceutical companies such as Dawa Limited, Africure Pharmaceuticals Limited, and Incepta Pharmaceuticals. The Lung Cancer Therapeutics Market in Tanzania is segmented into different types of cancer and different therapy types. Some of the major factors affecting the Tanzania lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies, and the presence of highly efficient drugs.
Tanzania Cancer Immunotherapy Market Analysis
Tanzania's cancer immunotherapy market is expected to witness growth from $45 Mn in 2022 to $83 Mn in 2030 with a CAGR of 8% for the forecasted year 2022-30. The growing prevalence of cancer and increased healthcare expenditure in Tanzania is responsible for the growth of the market. The Tanzania cancer immunotherapy market is segmented by type, application, and end user. Tanga Pharmaceuticals, Moraf Pharmaceutical, and Amgen are the major players in the Tanzania cancer immunotherapy market.
Tanzania Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Tanzania Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Tanzania Acne Therapeutics Market, offering unmatched value, accuracy, and expert insights.
Tanzania Acne Drugs Market Analysis
This report presents a strategic analysis of the Tanzania Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Tanzania Acne Drugs Market, offering unmatched value, accuracy, and expert insights.
Switzerland Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Switzerland Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Switzerland Orphan Diseases Drugs Market, offering unmatched value, accuracy, and expert insights.
Switzerland Oncology Drugs Market Analysis
This report presents a strategic analysis of the Switzerland Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Switzerland Oncology Drugs Market, offering unmatched value, accuracy, and expert insights.
Switzerland Dialysis Market Analysis
This report presents a strategic analysis of the Switzerland Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Switzerland Dialysis Market, offering unmatched value, accuracy, and expert insights.
South Africa Adult Malignant Glioma Therapeutics Market Analysis
The South Africa Adult Glioma Therapeutics Market is valued at around $14 Mn in 2022 and is projected to reach $31 Mn by 2030, exhibiting a CAGR of 10.13% during the forecast period. There is potential for higher demand for therapies as glioma diagnosis and treatment become more accessible in South Africa due to advancements in glioblastoma awareness, changing demographics, growing healthcare infrastructure, and changing treatment choices. Key players in the South Africa Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Aspen, Spectrum Pharmaceuticals, Adcock Ingram, Pharmatrans etc among others
Vietnam Adult Malignant Glioma Therapeutics Market Analysis
The Vietnam Adult Glioma Therapeutics Market is valued at around $11 Mn in 2022 and is projected to reach $22 Mn by 2030, exhibiting a CAGR of 9.13% during the forecast period. Vietnam's pharmaceutical sector heavily relies on imported drugs, particularly specialized ones like glioma treatments, with local companies focusing on generic versions for the price-sensitive market, while the country lacks regional participants, creating opportunities for new drugs to capture market share in response to the growing demand for effective glioma treatments. Key players in the Vietnam Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Stada Vietnam, Mekophar, Boston-Vietnam Pharma, Novogene, etc. among others.
US Adult Malignant Glioma Therapeutics Market Analysis
The US Adult Glioma Therapeutics Market is valued at around $924 Mn in 2022 and is projected to reach $1.576 Bn by 2030, exhibiting a CAGR of 6.9% during the forecast period. The increasing prevalence of metastatic glioma, driven by demographic shifts, advancements in diagnostic tools, and a rise in glioblastoma cases, coupled with the promise of targeted therapies based on genetic mutations, less invasive treatment options, and growing public awareness, collectively fuel the expansion of the market. Key players in the US Adult Malignant Glioma Therapeutics Market include Bristol-Myers Squibb, Roche, Novartis, Optune, Inc., Novocure, Arbor Pharmaceuticals, Elekta AB and Varian Medical Systems, Inc. among others
UK Adult Malignant Glioma Therapeutics Market Analysis
The UK Adult Glioma Therapeutics Market is valued at around $57 Mn in 2022 and is projected to reach $98 Mn by 2030, exhibiting a CAGR of 6.9% during the forecast period. A powerful convergence of factors is driving the UK Adult Malignant Glioma Therapeutics Market, including an increasing glioma burden, an aging population, a focus on customized therapy, and active research and development initiatives, both by the government and other market players. Key players in the UK Adult Malignant Glioma Therapeutics Market include companies like Merck & Co., Bristol-Myers Squibb, Roche, AbbVie, Azurity Pharmaceuticals, Aptevo Therapeutics, Peptinib Ltd., Bio-Rad Laboratories, Novocure, Pfizer etc.
UAE Adult Malignant Glioma Therapeutics Market Analysis
The UAE Adult Glioma Therapeutics Market is valued at around $11 Mn in 2022 and is projected to reach $23 Mn by 2030, exhibiting a CAGR of 9.9% during the forecast period. The UAE Market is fuelled due to drivers like increasing partnerships with globally established firms and research institutions, an increased aging population and acceptance and investments in technological advancements by the government to decrease healthcare problems. Key players in the UAE Adult Malignant Glioma Therapeutics Market include companies like Arbor Pharmaceuticals, Amneal Pharmaceuticals, Karyopharm, Roche, Bio-Rad Laboratories, Azurity Pharmaceuticals and Merck & Co. among others.
Spain Adult Malignant Glioma Therapeutics Market Analysis
The Spain Adult Glioma Therapeutics Market is valued at around $42 Mn in 2022 and is projected to reach $78 Mn by 2030, exhibiting a CAGR of 7.9% during the forecast period. The market growth is driven by increased healthcare spending by the government, increasing needs due to aging population and thus increased prevalence of the disease. Key players in the Spain Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Celyad, AbbVie, CureVac, Celyad, Vaxxilon, Oncolytics Biotech, Elekta, Varian Medical Systems etc.
Singapore Adult Malignant Glioma Therapeutics Market Analysis
The Singapore Adult Glioma Therapeutics Market is valued at around $3 Mn in 2022 and is projected to reach $5 Mn by 2030, exhibiting a CAGR of 9.5% during the forecast period. The aging population, better diagnosis and healthcare infrastructure, and more awareness among some of the factors contributing to the industry's growth, which in turn is fueling demand for treatments and creating new avenues for the glioma therapeutics market to expand. Key players in the Singapore Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Cellagenics, ASTAR, Novogene, Oncohereos Pharma etc. among others.
Saudi Arabia Adult Malignant Glioma Therapeutics Market Analysis
The Saudi Arabia Adult Glioma Therapeutics Market is valued at around $37 Mn in 2022 and is projected to reach $83 Mn by 2030, exhibiting a CAGR of 10.4% during the forecast period. An upsurge in the market is being driven by factors such as increased general awareness, tailored medication preferences, increased government backing, and demographic and urbanisation shifts. Key players in the Saudi Arabia Adult Malignant Glioma Therapeutics Market include companies like Mylan N.V., Teva Pharmaceuticals, Sanofi, Pfizer, GlaxoSmithKline plc., Novartis, Bayer, Merck & Co, etc.
Philippines Adult Malignant Glioma Therapeutics Market Analysis
The Philippines Adult Glioma Therapeutics Market is valued at around $5 Mn in 2022 and is projected to reach $10 Mn by 2030, exhibiting a CAGR of 9.4% during the forecast period. The market is expanding due to trends in innovative therapeutics, growing government funding, and the lack of regional competitors, which presents chances for new drugs to fill unmet needs. Key players in the Philippines Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Unilab, Generika, Novocure, Mercury etc. among others
